Dare Bioscience, Inc. Debt Instrument, Interest Rate, Stated Percentage
Dare Bioscience, Inc. (DARE) had Debt Instrument, Interest Rate, Stated Percentage of 1.00% as of 2020-04-30, per its 10-Q filed 2020-11-12.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2020-11-12
- 2020-04-30: Debt Instrument, Interest Rate, Stated Percentage 1.00%.
- 2016-12-31: Debt Instrument, Interest Rate, Stated Percentage 8.00%.
- 2016-06-30: Debt Instrument, Interest Rate, Stated Percentage 8.00%.
- 2014-09-30: Debt Instrument, Interest Rate, Stated Percentage 7.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2020-04-30 | 1.00% 10-Q · filed 2020-11-12 |
| 2016-12-31 | 8.00% 8-K/A · filed 2017-10-02 |
| 2016-06-30 | 8.00% 8-K/A · filed 2017-10-02 |
| 2014-09-30 | 7.00% 10-Q · filed 2014-11-13 |
| 2014-06-30 | 7.00% 10-Q · filed 2014-08-12 |
| 2014-03-31 | 7.00% 10-K · filed 2015-03-19 |
| 2013-08-31 | 7.00% 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |